Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic M Quitkin

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Depression With Atypical Features: Diagnostic Validity, Prevalence, and TreatmentFrederic M. Quitkin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2002
Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?Jonathan W Stewart, Patrick J McGrath, Frederic M Quitkin
Journal of Abnormal Psychology|June 6, 2003
Do age of onset and course of illness define biologically distinct groups within atypical depression?Jonathan W Stewart, Gerard E Bruder, Patrick J McGrath, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 4, 2009
DSM-IV depression with atypical features: is it valid?Jonathan W Stewart, Patrick J McGrath, Frederic M Quitkin, et al.
Journal of Affective Disorders|June 7, 2005
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctionsJonathan W Stewart, Frederic M Quitkin, Patrick J McGrath, et al.
Journal of Psychiatric Practice|October 13, 2009
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?Jonathan W Stewart, Patrick J McGrath, Rodeborah A Deliyannides, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2004
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapseAndrew A Nierenberg, Frederic M Quitkin, Charlotte Kremer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 9, 2004
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and menGerard E Bruder, Jonathan W Stewart, Patrick J McGrath, et al.
Biological Psychiatry|December 7, 2007
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findingsGerard E Bruder, James P Sedoruk, Jonathan W Stewart, et al.
Journal of Abnormal Psychology|August 2, 2002
Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric facesGerard E Bruder, Jonathan W Stewart, Patrick J McGrath, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Depression With Atypical Features: Diagnostic Validity, Prevalence, and TreatmentFrederic M. Quitkin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2002
Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?Jonathan W Stewart, Patrick J McGrath, Frederic M Quitkin
Journal of Abnormal Psychology|June 6, 2003
Do age of onset and course of illness define biologically distinct groups within atypical depression?Jonathan W Stewart, Gerard E Bruder, Patrick J McGrath, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 4, 2009
DSM-IV depression with atypical features: is it valid?Jonathan W Stewart, Patrick J McGrath, Frederic M Quitkin, et al.
Journal of Affective Disorders|June 7, 2005
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctionsJonathan W Stewart, Frederic M Quitkin, Patrick J McGrath, et al.
Journal of Psychiatric Practice|October 13, 2009
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?Jonathan W Stewart, Patrick J McGrath, Rodeborah A Deliyannides, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2004
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapseAndrew A Nierenberg, Frederic M Quitkin, Charlotte Kremer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 9, 2004
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and menGerard E Bruder, Jonathan W Stewart, Patrick J McGrath, et al.
Biological Psychiatry|December 7, 2007
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findingsGerard E Bruder, James P Sedoruk, Jonathan W Stewart, et al.
Journal of Abnormal Psychology|August 2, 2002
Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric facesGerard E Bruder, Jonathan W Stewart, Patrick J McGrath, et al.
Pageof 3